Sign in
4

Changes in Ownership

Fulgent Genetics, Inc. Filed Acc 0001209191-22-014778

Chief Operating Officer sold 622 shares at $63.30 ($39,370)

  • Chief Operating Officer acquired 41,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Xie Jian · Chief Operating Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-28 Grant or award : show line 1 in the form +9,000 306,234 D
2022-02-28 Grant or award : show line 2 in the form +32,000 338,234 D
2022-03-01 Sale : show line 3 in the form −622 $63.30 $39,370 337,612 D
Open-market sales · 622 sh · avg $63.30 · $39,370
Loading xslF345X03/doc4.xml…